Ghost Tree Capital, LLC Elevation Oncology, Inc. Transaction History

Ghost Tree Capital, LLC

  • $267 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.35 - $5.17 $822,500 - $1.81 Million
350,000 Added 140.0%
600,000 $1.62 Million
Q1 2024

May 15, 2024
BUY
$0.59 - $5.13 $147,500 - $1.28 Million
250,000 New
250,000 $1.28 Million
Q3 2021

Nov 15, 2021
SELL
$7.66 - $16.11 $766,000 - $1.61 Million
-100,000 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$11.44 - $13.57 $1.14 Million - $1.36 Million
100,000 New
100,000 $1.36 Million

Others Institutions Holding ELEV

# of Institutions
68
Shares Held
45.4M
Call Options Held
700
Put Options Held
27.6K
View Full List

About Elevation Oncology, Inc.

ELEV Quotes by TradingView
  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $12.3M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email